Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Clinical trial NCT03379428 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03379428
- Sponsor
- US Oncology Research
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2025-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.